Press Releases

BOSTON, Aug. 27, 2019 /PRNewswire/ -- The All of Us research program, CAR-T therapies, increasingly accessible genetic testing, and other applications for new medical data are all starting to make the concept of precision medicine a reality. As these new data-driven, personalized treatment plans begin to enter clinical practice in specialty care settings such as on

TORONTO and CAMBRIDGE, MA, Aug. 27, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, has added Dr. Andre Strydom to its scientific adv

NEW YORK, Aug. 27, 2019 /PRNewswire/ -- Sentinel Capital Partners, a private equity firm that invests in promising companies at the lower end of the midmarket, today announced the acquisition of SSJA Bariatric Management, LLC ("SSJA"), the leading provider of administrative support services to bariatric surgery offices in the New York me

NESS ZIONA, Israel, Aug. 27, 2019 /PRNewswire/ -- BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced completion of construction of a new state-of-the-art manufacturing facility. The new facility is located at the company's headquarters i

DAVIE, Florida, Aug. 27, 2019 /PRNewswire/ -- LeafyWell (www.LeafyWell.com), a subsidiary of NxGen Brands, Inc  (NXGB), today announces having public figure, John Orlandini aka "JohnnyO" as a designated brand ambassador for LeafyWell and "NXGB". JohnnyO&nbs

CARLSBAD, Calif., Aug. 27, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, announced today that GSK exercised its option to license Ionis' antisense medicines for people with chronic hepatitis B virus (CHB) infection following positive Phase 2 results.

ROCKVILLE, Md., Aug. 27, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that an interim trial update from the RGX-314 Phase I/IIa clinical trial for the treatmen

HOUSTON, Aug. 27, 2019 /PRNewswire/ -- Legal-Bay, the premier Pre Settlement Funding Company, announced today that they are expanding their surgical funding department. Surgery funding is a fast and easy way for plaintiffs to get financing to pay for a medically-necessary surgical procedure when no insurance exists. Unfortunately, just because you've been injured—

AURORA, Colo., Aug. 27, 2019 /PRNewswire/ -- Machavert Pharmaceuticals, a preclinical stage pharmaceutical company focused on precision medicine cancer therapies, announced today that it has obtained a full exclusive license on RAL GTPase (RAL) inhibitors from the University of Colorado. The licensed patent portfolio covers small molecule RAL inhibitors against KRAS mut

DALLAS and SAN DIEGO, Aug. 27, 2019 /PRNewswire/ -- AMN Healthcare, the leader and innovator in healthcare workforce solutions and staffing services, has named Christine Mackey-Ross as Lead Executive Partner of Phillips DiPisa, an AMN Healthcare company.